Literature DB >> 7815786

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease.

J D Cooper1, E P Trulock, A N Triantafillou, G A Patterson, M S Pohl, P A Deloney, R S Sundaresan, C L Roper.   

Abstract

We undertook surgical bilateral lung volume reduction in 20 patients with severe chronic obstructive pulmonary disease to relieve thoracic distention and improve respiratory mechanics. The operation, done through median sternotomy, involves excision of 20% to 30% of the volume of each lung. The most affected portions are excised with the use of a linear stapling device fitted with strips of bovine pericardium attached to both the anvil and the cartridge to buttress the staple lines and eliminate air leakage through the staple holes. Preoperative and postoperative assessment of results has included grading of dyspnea and quality of life, exercise performance, and objective measurements of lung function by spirometry and plethysmography. There has been no early or late mortality and no requirement for immediate postoperative ventilatory assistance. Follow-up ranges from 1 to 15 months (mean 6.4 months). The mean forced expiratory volume in 1 second has improved by 82% and the reduction in total lung capacity, residual volume, and trapped gas has been highly significant. These changes have been associated with marked relief of dyspnea and improvement in exercise tolerance and quality of life. Although the follow-up period is short, these preliminary results suggest that bilateral surgical volume reduction may be of significant value for selected patients with severe chronic obstructive pulmonary disease.

Entities:  

Mesh:

Year:  1995        PMID: 7815786     DOI: 10.1016/S0022-5223(95)70426-4

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  77 in total

1.  Lung volume reduction surgery results in pulmonary emphysema. Changes in pulmonary function.

Authors:  Y Yoshinaga; A Iwasaki; K Kawahara; T Shirakusa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-09

2.  Emphysema sufferers breathe easier.

Authors:  J D Miller
Journal:  CMAJ       Date:  1999-11-02       Impact factor: 8.262

3.  Correlation of unilateral thoracoscopic lung volume reduction with improvement in lung function and exercise performance in patients with severe pulmonary emphysema.

Authors:  Y Kaiwa; Y Kurokawa; K Ando; A Nakagawa; K Mitsui; H Miki; H Kurosawa; W Hida; S Satomi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 4.  Lung volume reduction surgery.

Authors:  D M Geddes
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

5.  Thoracoscopic lung volume reduction surgery for emphysema. Evaluation using ventilation-perfusion scintigraphy.

Authors:  K Nezu; K Kushibe; N Sawabata; M Takahama; T Tojo; S Taniguchi; Y Sasaki; T Imai; S Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-06

Review 6.  Surgery and the respiratory muscles.

Authors:  N M Siafakas; I Mitrouska; D Bouros; D Georgopoulos
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

Review 7.  Recent advances: Respiratory medicine.

Authors:  H A Kerstjens; H J Groen; W van Der Bij
Journal:  BMJ       Date:  2001-12-08

8.  Lung volume reduction surgery and nutritional status in patients with severe emphysema.

Authors:  K Nezu; T Kawaguchi; M Kimura; M Yasukawa; K Kushibe; S Taniguchi; M Yoshikawa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

9.  Changes in ventilatory mechanics and diaphragmatic function after lung volume reduction surgery in patients with COPD.

Authors:  E M Tschernko; W Wisser; T Wanke; M A Rajek; M Kritzinger; H Lahrmann; M Kontrus; H Benditte; W Klepetko
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 10.  State of the art in thoracospic surgery: a personal experience of 2000 videothoracoscopic procedures and an overview of the literature.

Authors:  G C Roviaro; F Varoli; C Vergani; M Maciocco
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.